Business Context and Reporting Period
This Form 8-K is a current report filed by Sonim Technologies, Inc. (not DNA X, Inc.) on September 14, 2021. The registrant is a Delaware corporation with its principal executive offices in Austin, Texas, and its common stock trades on the Nasdaq Capital Market under the symbol SONM.
Key Financial Metrics
This filing is a regulatory disclosure regarding a corporate action and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. No financial metrics are reported in this document.
Material Changes
The primary material event disclosed is the Board of Directors' approval of a one-for-ten reverse stock split of the Company's issued and outstanding common stock. This action was authorized by stockholders at the annual meeting on September 29, 2020, which approved a split ratio between one-for-two and one-for-twelve.
Guidance, Outlook, and Management Commentary
- Implementation Timeline: The reverse stock split is expected to become effective at 5:00 p.m. Eastern Time on September 15, 2021.
- Trading Resumption: Common stock is expected to begin trading on a split-adjusted basis when the market opens on September 16, 2021.
- Conversion Ratio: Every ten (10) issued and outstanding shares of Common Stock will be converted into one (1) share of Common Stock.
- Legal Status: The information in this Item 7.01 and the accompanying press release (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings.
Investor Verification Checklist
- Verify the effective date and time of the reverse stock split (September 15, 2021, 5:00 p.m. ET).
- Confirm the trading start date for split-adjusted shares (September 16, 2021).
- Review the press release (Exhibit 99.1) for details on fractional share handling and record date specifics.
- Check subsequent filings for updated financial data, as this 8-K contains no financial performance metrics.